
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-03-24RVPHWSCHEDULE 13D/AAmendment No. 13 to Schedule 13D for REVIVA PHARMACEUTICALS HOLDINGS, INC.MEDIUM
This filing is an amendment to a previous Schedule 13D, filed by Parag Saxena, regarding his beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock. As of March 24, 2026, Mr. Saxena beneficially owns 363,280 shares, representing approximately 2.8% of the outstanding shares. This ownership includes d...
Biotechnologyownership +2.80%
2026-03-24REVIVA PHARMACEUTICALS HOLDINGS, INC.SCHEDULE 13D/AAmendment No. 13 to Schedule 13D for REVIVA PHARMACEUTICALS HOLDINGS, INC.DuplicateMEDIUM
This filing is an amendment to a previous Schedule 13D, filed by Parag Saxena, regarding his beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock. As of March 24, 2026, Mr. Saxena beneficially owns 363,280 shares, representing approximately 2.8% of the outstanding shares. This ownership includes d...
Biotechnologyownership +2.80%
Sponsored
Sponsored
2026-03-23BGLSCHEDULE 13D/AAmendment to Schedule 13D Filing for Blue Gold LtdMEDIUM
This filing is an amendment to a previously filed Schedule 13D for Blue Gold Ltd, concerning Class A ordinary shares. Andrew Cavaghan and associated entities collectively hold beneficial ownership of 3,984,229 shares, representing approximately 11.3% of the issuer's outstanding shares. The amendment details several tra...
Goldownership +11.30%
2026-03-23Blue Gold LtdSCHEDULE 13D/AAmendment to Schedule 13D Filing for Blue Gold LtdDuplicateMEDIUM
This filing is an amendment to a previously filed Schedule 13D for Blue Gold Ltd, concerning Class A ordinary shares. Andrew Cavaghan and associated entities collectively hold beneficial ownership of 3,984,229 shares, representing approximately 11.3% of the issuer's outstanding shares. The amendment details several tra...
Goldownership +11.30%
Sponsored